The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2021 | COVID-19 vaccination responses in patients with blood cancers
Paresh Vyas, MRCP, FRCP, FRCPath, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, discusses the response to COVID-19 vaccinations in patients with blood cancers. Compared to the general populace, patients with blood cancers will have different responses to vaccinations, and responses will also differ across various blood cancers. Vaccines tend to be less effective in patients with cancers or those receiving immunosuppressive treatments, as well as patients who receive more aggressive chemotherapy treatments. This interview took place at the 2021 British Society for Haematology Annual Scientific Meeting.
